Several reports identified that the NRAS, KRAS, and BRAF mutation frequency rises from 24% in SMM [86] to 50% in newly diagnosed MM cases [87,88,89,90,91] and up to 80% in relapsed/refractory MM (RRMM) patients [92,93]. This evidence concerns the gene BRAF and Miyoshi myopathy.